Neuroimage Genome Study of Neuroplasticity Associated With Microgravity

April 1, 2024 updated by: Xin Lou, Chinese PLA General Hospital
This clinical trial investigates the neuroplasticity and cognitive status changes of the human brain in microgravity. To explore the relationship between cognitive status changes and brain functional activities, gray matter and white matter changes under microgravity exposure, screen and identify representative image markers, so as to provide decision-making information for the cognitive status changes of relevant personnel under microgravity environment.

Study Overview

Detailed Description

MRI has the advantage of non-invasive and non-radiation, and imaging the human brain after exposure to microgravity can reveal the neuroplastic changes in the astronaut's brain and discover the characteristics of functional activities behind it. The purpose of this study is to explore the image features and cognitive state related information related to the changes of human brain neuroplasticity under microgravity environment, and to identify the related image markers. At the same time, the pathophysiological mechanism is preliminarily discussed in this study. This study is helpful for us to explore the sensitivity of different brain structures and brain functions to space microgravity environment, so as to further understand the role and influence of space missions on brain health.

Study Type

Observational

Enrollment (Actual)

26

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • Chinese PLA General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Volunteers who underwent 60 days of the Head-Down tilt Bed Rest test.

Description

Inclusion Criteria:

  • Male aged 18-60 years
  • No mental or other neurological disorders, no history of drug or alcohol abuse
  • Generally in good condition, no clear major physical diseases, no hearing disorders
  • No metal foreign bodies in the body, no contraindications to MRI scanning
  • No claustrophobia
  • Agree to participate in the clinical study and sign the informed consent

Exclusion Criteria:

  • There are electronic implants or metal foreign bodies, such as cardiac pacemakers
  • People with aneurysm surgery and intracranial aneurysm clip
  • People who have had heart surgery and used artificial heart valves
  • Having family planning
  • Uncontrolled epilepsy or mental illness, can't cooperate with MRI examination
  • Severe claustrophobia, can't cooperate with magnetic resonance examination
  • Other circumstances that the clinical trial personnel consider inappropriate to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Local brain functional activity
Time Frame: 60 days after the Head-Down tilt Bed Rest test
Based on resting-state functional MRI images, the changes of local brain functional activity before and after the Head-Down tilt Bed Rest test were compared.
60 days after the Head-Down tilt Bed Rest test
Brain functional connectivity
Time Frame: 60 days after the Head-Down tilt Bed Rest test
Based on resting-state functional MRI images, the changes of brain functional connectivity before and after the Head-Down tilt Bed Rest test were compared.
60 days after the Head-Down tilt Bed Rest test
Brain structure - Morphology
Time Frame: 60 days after the Head-Down tilt Bed Rest test
Based on 3D-T1WI, the changes of brain structure before and after the Head-Down tilt Bed Rest test were compared.
60 days after the Head-Down tilt Bed Rest test
Brain fiber bundle and brain Diffusion index
Time Frame: 60 days after the Head-Down tilt Bed Rest test
Based on diffusion tensor imaging, the changes of brain fiber bundle and brain diffusion index before and after the Head-Down tilt Bed Rest test were compared.
60 days after the Head-Down tilt Bed Rest test
Brain blood flow
Time Frame: 60 days after the Head-Down tilt Bed Rest test
Based on arterial spin labeling, the changes of brain blood flow before and after the Head-Down tilt Bed Rest test were compared.
60 days after the Head-Down tilt Bed Rest test
Imaging indexes and clinical scale scores
Time Frame: 60 days after the Head-Down tilt Bed Rest test
Based on the changes of relevant imaging indexes and the changes of relevant clinical scale scores, explore the correlation between the changes of relevant imaging indexes and relevant clinical scales scores.
60 days after the Head-Down tilt Bed Rest test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Estimated)

October 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

April 1, 2024

First Submitted That Met QC Criteria

April 1, 2024

First Posted (Actual)

April 5, 2024

Study Record Updates

Last Update Posted (Actual)

April 5, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on MRI

Clinical Trials on Head-Down tilt Bed Rest test

3
Subscribe